HCA Healthcare HCA NYSE · Healthcare · United States
$499.15 -0.30% -$1.51
Summary
74 / 100 · Bulios Score
What speaks for it
- It earns 19 USD a year on every 100 USD of invested capital.
- The share price is below the Bulios Fair Price.
- Earnings per share grew by 14% a year over the last 3 years.
- It bought back its own shares for $10.1B in the last fiscal year, 9.6% of its market value.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 15.4 USD for 1 USD of yearly profit. Over the last five years it was 13.7 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 8.0% a year over 5 years. Over the last 3 years it grew by 7.9% a year. For the next fiscal year analysts expect revenue to grow by 4.7%. Earnings per share grew by 14% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 78 USD
- Sales and administration 6.4 USD
- Taxes and other 6.7 USD
- Net profit 8.6 USD
Net profit, industry median (Medical - Care Facilities) 7.3 USD
Out of every 100 USD of revenue, 8.6 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 8.8 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.61%
- Paid out of profit
- 9.4%
- Raised in a row
- 5 years
You receive $3.06 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 29
- Hold 15
- Sell 2
Today's price within the analysts' price targets
The average target of $459.06 is 8.0% below today's price. 63% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Managed Care And Other Insurers 51%
- Managed Medicare 18%
- Medicare 15%
- Medicaid 8.1%
- Managed Medicaid 5.0%
- Other 2.5%
By region
- American Group 37%
- Atlantic Group 34%
- National Group 29%
Managed Care And Other Insurers brings in 51% of revenue. Medicaid grew fastest, by 27% a year.
Segments in detail